Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agranular CD4+/CD56+ cutaneous neoplasm.

T Touahri1, H Belaouni, H Mossafa

  • 1Service d'Hematologie Clinique, Centre hospitalier V. Dupouy, Argenteuil, France.

Leukemia & Lymphoma
|October 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dupilumab in Eosinophilic Gastrointestinal Disorders With Extraesophageal Involvement: A Pediatric Case Series and Systematic Review.

Journal of investigational allergology & clinical immunology·2025
Same author

Dalbavancin for prosthetic joint infections: Empirical treatment.

Infectious diseases now·2025
Same author

Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF.

Infectious diseases now·2023
Same author

Can we rely on histopathological results for the diagnosis of prosthetic joint infection?

Infectious diseases now·2023
Same author

Molecular and clinical diversity in primary central nervous system lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Characteristics of Enterobacter cloacae prosthetic joint infections.

Medecine et maladies infectieuses·2019
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

A rare CD4+ CD56+ cutaneous neoplasm, potentially blastic NK-cell leukemia/lymphoma, showed aggressive progression to a leukemic phase. Despite chemotherapy, the patient experienced early hematological relapse, highlighting the disease

Area of Science:

  • Hematology
  • Oncology
  • Dermatopathology

Background:

  • CD4+ CD56+ cutaneous neoplasms represent a rare and recently described malignant entity.
  • The exact origin and classification of these neoplasms, sometimes termed blastic or agranular NK-cell leukemia/lymphoma, remain uncertain.
  • Understanding the behavior of this neoplasm is crucial due to its aggressive nature.

Observation:

  • A case study of a 75-year-old patient with a primary CD4+ CD56+ cutaneous neoplasm is presented.
  • The neoplasm exhibited undifferentiated morphology with no cytoplasmic granules.
  • Histological analysis confirmed infiltration primarily in the dermis.

Findings:

  • The patient's neoplasm showed an aggressive clinical course, evolving to a leukemic phase despite standard lymphoma chemotherapy.

Related Experiment Videos

  • Immunophenotyping revealed expression of CD4, CD56, CD68, CD33, CD7, CD2, CD45RA, and CD38.
  • Genetic analysis indicated germline configuration for T-cell receptor and immunoglobulin heavy chain genes, with complex chromosomal abnormalities including del(5q).

    • Implications:

    • This case highlights the aggressive nature and potential for early hematological relapse in CD4+ CD56+ cutaneous neoplasms.
    • The findings contribute to the limited literature on this rare entity, emphasizing the need for further research into its pathogenesis and optimal treatment strategies.
    • The immunophenotypic and cytogenetic profile provides valuable data for differential diagnosis and understanding disease biology.